2018 Center for Biologics Evaluation and Research Science Symposium, 12582 [2018-05805]
Download as PDF
<![CDATA[
12582
Federal Register / Vol. 83, No. 56 / Thursday, March 22, 2018 / Notices
science conducted at CBER by
showcasing how scientific research
informs regulatory decision making and
to provide a forum for developing
collaborations within FDA and with
external organizations.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–1094]
2018 Center for Biologics Evaluation
and Research Science Symposium
AGENCY:
II. Topics for Discussion at the Public
Symposium
Food and Drug Administration,
HHS.
ACTION:
Notice of public symposium.
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
symposium entitled ‘‘2018 Center for
Biologics Evaluation and Research
Science Symposium.’’ The purpose of
the public symposium is to discuss
scientific topics related to the regulation
of biologics and highlight science
conducted at the Center for Biologics
Evaluation and Research (CBER) by
showcasing how scientific research
informs regulatory decision making and
to provide a forum for developing
collaborations within FDA and with
external organizations. The symposium
will include presentations by experts
from academic institutions, government
agencies, and research institutions.
DATES: The public symposium will be
held on June 25 and 26, 2018, from 9
a.m. to 3 p.m. See the SUPPLEMENTARY
INFORMATION section for registration date
and information.
ADDRESSES: The public symposium will
be held at FDA’s White Oak campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993.
Entrance for the public symposium
participants (non-FDA employees) is
through Bldg. 1, where routine security
check procedures will be performed. For
parking and security information, please
refer to https://www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
SUMMARY:
daltland on DSKBBV9HB2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Sherri Revell or Loni Warren
Henderson, Food and Drug
Administration, Center for Biologics
Evaluation and Research, 10903 New
Hampshire Ave., Bldg. 71, Rm. 1118,
Silver Spring, MD 20993, 240–402–
8010, email: CBERPublicEvents@
fda.hhs.gov (subject line: CBER Science
Symposium).
SUPPLEMENTARY INFORMATION:
I. Background
The purpose of the public symposium
is to discuss scientific topics related to
the regulation of biologics and highlight
VerDate Sep<11>2014
19:32 Mar 21, 2018
Jkt 244001
The public symposium will include
presentations on the following topics:
(1) Emerging and re-emerging diseases;
(2) diverse types of data in regulatory
decision making; (3) immune response
to vaccination; (4) immunotherapy; (5)
new technologies for research and
treatments; (6) the role of the
microbiome in human disease; and (7)
regenerative medicine.
III. Participating in the Public
Symposium
Registration: To register for the public
symposium, please visit the following
website: https://www.eventbrite.com/e/
2018-center-for-biologics-evaluationand-research-cber-science-symposiumtickets-39525851887. Please provide
complete contact information for each
attendee, including name, title,
affiliation, address, email, and
telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public symposium (either
in person or by webcast) (see Streaming
Webcast of the Public Symposium) must
register online by June 18, 2018,
midnight Eastern Time. Early
registration is recommended because
seating is limited. There will be no
onsite registration; therefore, FDA may
limit the number of participants from
each organization. Registrants will
receive confirmation when they have
been accepted.
If you need special accommodations,
due to a disability, please contact Sherri
Revell or Loni Warren Henderson no
later than June 11, 2018.
Streaming Webcast of the Public
Symposium: This public symposium
will also be webcast. A link to the live
webcast of this symposium will be
provided upon registration at https://
www.eventbrite.com/e/2018-center-forbiologics-evaluation-and-research-cberscience-symposium-tickets39525851887. Persons interested in
viewing the live webcast must register
online by June 18, 2018. Early
registration is recommended because
webcast connections are limited. A
video record of the public symposium
will be available at https://www.fda.gov/
BiologicsBloodVaccines/NewsEvents/
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
WorkshopsMeetingsConferences/
default.htm for 1 year.
If you have never attended a Connect
Pro event before, test your connection at
https://collaboration.fda.gov/common/
help/en/support/meeting_test.htm. To
get a quick overview of the Connect Pro
program, visit https://www.adobe.com/
go/connectpro_overview. FDA has
verified the website addresses in this
document as of the date this document
publishes in the Federal Register, but
websites are subject to change over time.
Dated: March 1, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018–05805 Filed 3–21–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2014–N–1027; FDA–
2017–N–1064; FDA–2014–D–0329; FDA–
2013–N–1429; FDA–2009–N–0505; and
FDA–2014–N–0192]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
SUMMARY:
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 83, Number 56 (Thursday, March 22, 2018)]
[Notices]
[Page 12582]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05805]
[[Page 12582]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-1094]
2018 Center for Biologics Evaluation and Research Science
Symposium
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public symposium.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
announcing the following public symposium entitled ``2018 Center for
Biologics Evaluation and Research Science Symposium.'' The purpose of
the public symposium is to discuss scientific topics related to the
regulation of biologics and highlight science conducted at the Center
for Biologics Evaluation and Research (CBER) by showcasing how
scientific research informs regulatory decision making and to provide a
forum for developing collaborations within FDA and with external
organizations. The symposium will include presentations by experts from
academic institutions, government agencies, and research institutions.
DATES: The public symposium will be held on June 25 and 26, 2018, from
9 a.m. to 3 p.m. See the SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public symposium will be held at FDA's White Oak campus,
10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room
(Rm. 1503), Silver Spring, MD 20993. Entrance for the public symposium
participants (non-FDA employees) is through Bldg. 1, where routine
security check procedures will be performed. For parking and security
information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
FOR FURTHER INFORMATION CONTACT: Sherri Revell or Loni Warren
Henderson, Food and Drug Administration, Center for Biologics
Evaluation and Research, 10903 New Hampshire Ave., Bldg. 71, Rm. 1118,
Silver Spring, MD 20993, 240-402-8010, email:
[email protected] (subject line: CBER Science Symposium).
SUPPLEMENTARY INFORMATION:
I. Background
The purpose of the public symposium is to discuss scientific topics
related to the regulation of biologics and highlight science conducted
at CBER by showcasing how scientific research informs regulatory
decision making and to provide a forum for developing collaborations
within FDA and with external organizations.
II. Topics for Discussion at the Public Symposium
The public symposium will include presentations on the following
topics: (1) Emerging and re-emerging diseases; (2) diverse types of
data in regulatory decision making; (3) immune response to vaccination;
(4) immunotherapy; (5) new technologies for research and treatments;
(6) the role of the microbiome in human disease; and (7) regenerative
medicine.
III. Participating in the Public Symposium
Registration: To register for the public symposium, please visit
the following website: https://www.eventbrite.com/e/2018-center-for-biologics-evaluation-and-research-cber-science-symposium-tickets-39525851887. Please provide complete contact information for each
attendee, including name, title, affiliation, address, email, and
telephone.
Registration is free and based on space availability, with priority
given to early registrants. Persons interested in attending this public
symposium (either in person or by webcast) (see Streaming Webcast of
the Public Symposium) must register online by June 18, 2018, midnight
Eastern Time. Early registration is recommended because seating is
limited. There will be no onsite registration; therefore, FDA may limit
the number of participants from each organization. Registrants will
receive confirmation when they have been accepted.
If you need special accommodations, due to a disability, please
contact Sherri Revell or Loni Warren Henderson no later than June 11,
2018.
Streaming Webcast of the Public Symposium: This public symposium
will also be webcast. A link to the live webcast of this symposium will
be provided upon registration at https://www.eventbrite.com/e/2018-center-for-biologics-evaluation-and-research-cber-science-symposium-tickets-39525851887. Persons interested in viewing the live webcast
must register online by June 18, 2018. Early registration is
recommended because webcast connections are limited. A video record of
the public symposium will be available at https://www.fda.gov/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/default.htm for 1 year.
If you have never attended a Connect Pro event before, test your
connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm. To get a quick overview of the Connect Pro program,
visit https://www.adobe.com/go/connectpro_overview. FDA has verified
the website addresses in this document as of the date this document
publishes in the Federal Register, but websites are subject to change
over time.
Dated: March 1, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-05805 Filed 3-21-18; 8:45 am]
BILLING CODE 4164-01-P
